Chromo Laboratories India Private Ltd, based in India, is a pharmaceutical company.
One of their notable products is CHLORTHALIDONE USP, with a corresponding US DMF Number 33071.
Remarkably, this DMF maintains an Active status since its submission on August 30, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 20, 2024, and payment made on May 07, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II